| dc.description.abstract |
NADH:ubiquinone oxidoreductase (complex I) deficiency is one of the most
frequently encountered causes of mitochondria1 respiratory chain disorders. One
of the major consequences of such a complex I deficiency is the production of
high levels of reactive oxygen species (ROS) and its deleterious effects on the
mitochondria and induction of apoptosis. Metallothioneins have been identified
as scavengers of ROS, probably due to its unique structural characteristics that
provide the ability to bind and reduce ROS.
The study investigated the putative protective role of metallothionein
overexpression in a complex I deficient cell line and establish whether this
protection was targeted against ROS or ROS-related consequences. It was also
necessary to establish whether different MT isoforms would lead to different
levels of protection in complex I deficient cells. MT-1B and MT-2A cDNA
sequences were respectively cloned into the plRESneo2 expression vector and
transfected into HeLa cells. The expression levels were characterised and
selected biochemical assays conducted.
Caspase 317 activity measurement and cell viability assays of rotenone-induced
complex I deficient cells revealed MT-1 B and especially MT-2A to protect against
apoptosis induction, whilst MT-2A also showed additional protection against
ROS-induced necrosis. Direct ROS quantification could not confirm MT
protection in rotenone-induced complex I deficient cells, but showed lower levels
of ROS production in t-BHP treated cells. Decreases in membrane potential also
appeared to be much less in MT-overexpressed complex I deficient cells. These
cells also showed a tendency towards better cellular morphology. Hence, the
results presented in this study support the hypothesis that both MT-1B and MT-
2A has some protective effect in complex I deficient cells. It does appear,
however, that MT-2A seems to be somewhat more effective in protection against
ROS, mtPTP formation, apoptosis and ROS-induced necrosis than MT-1 B. |
|